Vapotherm (NYSE:VAPO) Trading Up 7%

Shares of Vapotherm Inc (NYSE:VAPO) were up 7% during mid-day trading on Friday . The stock traded as high as $23.00 and last traded at $23.00. Approximately 156,908 shares changed hands during trading, an increase of 245% from the average daily volume of 45,418 shares. The stock had previously closed at $21.50.

A number of brokerages have recently weighed in on VAPO. Canaccord Genuity lifted their price objective on Vapotherm from $22.00 to $27.00 and gave the company a “buy” rating in a research note on Wednesday, March 13th. Zacks Investment Research cut Vapotherm from a “hold” rating to a “sell” rating in a research note on Saturday, March 16th. One investment analyst has rated the stock with a sell rating and four have issued a buy rating to the company. The stock currently has an average rating of “Buy” and an average target price of $26.50.

The stock’s fifty day simple moving average is $18.38. The company has a quick ratio of 5.34, a current ratio of 6.35 and a debt-to-equity ratio of 1.01.

Vapotherm (NYSE:VAPO) last released its earnings results on Tuesday, May 7th. The company reported ($0.76) earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of ($0.79) by $0.03. The company had revenue of $12.30 million during the quarter, compared to analysts’ expectations of $11.90 million. As a group, analysts expect that Vapotherm Inc will post -3.15 EPS for the current fiscal year.

Large investors have recently added to or reduced their stakes in the stock. Pura Vida Investments LLC purchased a new position in Vapotherm in the fourth quarter valued at $2,984,000. BlackRock Inc. purchased a new stake in Vapotherm during the 4th quarter worth about $6,248,000. Lord Abbett & CO. LLC purchased a new stake in Vapotherm during the 4th quarter worth about $7,573,000. Northern Trust Corp purchased a new stake in Vapotherm during the 4th quarter worth about $1,156,000. Finally, New York State Common Retirement Fund purchased a new stake in Vapotherm during the 4th quarter worth about $118,000. Hedge funds and other institutional investors own 46.91% of the company’s stock.

About Vapotherm (NYSE:VAPO)

Vapotherm, Inc, a medical technology company, focuses on the development and commercialization of proprietary Hi-VNI technology products used to treat patients of various ages suffering from respiratory distress worldwide. The company offers precision flow systems, such as Precision Flow Hi-VNI, Precision Flow Plus, Precision Flow Classic, and Precision Flow Heliox that use Hi-VNI technology to deliver heated, humidified, and oxygenated air at a high velocity to patients through a small-bore nasal interface.

Read More: What is the Producer Price Index (PPI)?

Receive News & Ratings for Vapotherm Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vapotherm and related companies with MarketBeat.com's FREE daily email newsletter.